The British Journal of Cancer is one of the most-cited general cancer journals, publishing significant advances in translational and clinical cancer research. It also publishes high-quality reviews and thought-provoking comment on all aspects of cancer prevention, diagnosis and treatment.
BJC welcomes research across all cancer types and has a particular focus on: metastasis, microenvironment, immunology and immunotherapy, targeted and next-generation therapeutics, chemotherapy and radiotherapy, mechanisms of resistance, clinical trials, genomics, epigenomics and precision medicine, epidemiology, metabolism and state-of-the art diagnostic approaches.
The British Journal of Cancer is owned by Cancer Research UK, the world’s leading cancer charity dedicated to saving lives through research.
The journal is separated into six general categories:
/// Clinical Studies
/// Translational Therapeutics
/// Molecular Diagnostics
/// Genetics and Genomics
/// Cellular and Molecular Biology
/// Epidemiology
Nam, Ga Eun; Cho, Kyung Hwan; Han, Kyungdo; Kim, Chul Min; Han, Byoungduck; Cho, Sung Jung; Jung, Seung Jin; Kwon, Yeongkeun; Kim, Yang Hyun; Kim, Do Hoon, et al.
ArticleIssue Date2019CitationBRITISH JOURNAL OF CANCER, v.121, no.3, pp.271 - 277PublisherNATURE PUBLISHING GROUP